Literature DB >> 26593314

Restricting Metformin in CKD: Continued Caution Warranted.

Connie M Rhee1, Kamyar Kalantar-Zadeh2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26593314      PMCID： PMC5937992          DOI： 10.1053/j.ajkd.2015.07.039

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN： 0272-6386            Impact factor:   8.860


× No keyword cloud information.
  10 in total

1.  Case records of the Massachusetts General Hospital. Case 23-2013. A 54-year-old woman with abdominal pain, vomiting, and confusion.

Authors:  Kamyar Kalantar-Zadeh; Raul N Uppot; Kent B Lewandrowski
Journal:  N Engl J Med       Date:  2013-07-10       Impact factor: 91.245

2.  Metformin in chronic kidney disease: more harm than help?

Authors:  Kamyar Kalantar-Zadeh; Connie M Rhee
Journal:  Lancet Diabetes Endocrinol       Date:  2015-06-17       Impact factor: 32.069

3.  Metformin Use in Type 2 Diabetes Mellitus With CKD: Is It Time to Liberalize Dosing Recommendations?

Authors:  Robert C Stanton
Journal:  Am J Kidney Dis       Date:  2015-05-08       Impact factor: 8.860

Review 4.  Metformin in patients with type 2 diabetes and kidney disease: a systematic review.

Authors:  Silvio E Inzucchi; Kasia J Lipska; Helen Mayo; Clifford J Bailey; Darren K McGuire
Journal:  JAMA       Date:  2014 Dec 24-31       Impact factor: 56.272

5.  Diabetic kidney disease: a report from an ADA Consensus Conference.

Authors:  Katherine R Tuttle; George L Bakris; Rudolf W Bilous; Jane L Chiang; Ian H de Boer; Jordi Goldstein-Fuchs; Irl B Hirsch; Kamyar Kalantar-Zadeh; Andrew S Narva; Sankar D Navaneethan; Joshua J Neumiller; Uptal D Patel; Robert E Ratner; Adam T Whaley-Connell; Mark E Molitch
Journal:  Am J Kidney Dis       Date:  2014-10       Impact factor: 8.860

6.  Lactic acidosis in metformin-treated patients. Prognostic value of arterial lactate levels and plasma metformin concentrations.

Authors:  J D Lalau; J M Race
Journal:  Drug Saf       Date:  1999-04       Impact factor: 5.606

7.  Metformin use and mortality in patients with advanced chronic kidney disease: national, retrospective, observational, cohort study.

Authors:  Szu-Chun Hung; Yu-Kang Chang; Jia-Sin Liu; Ko-Lin Kuo; Yu-Hsin Chen; Chih-Cheng Hsu; Der-Cherng Tarng
Journal:  Lancet Diabetes Endocrinol       Date:  2015-06-17       Impact factor: 32.069

Review 8.  Updates on the management of diabetes in dialysis patients.

Authors:  Connie M Rhee; Angela M Leung; Csaba P Kovesdy; Katherine E Lynch; Gregory A Brent; Kamyar Kalantar-Zadeh
Journal:  Semin Dial       Date:  2014-03       Impact factor: 3.455

9.  KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update.

Authors: 
Journal:  Am J Kidney Dis       Date:  2012-11       Impact factor: 8.860

10.  Metformin-associated lactic acidosis: a prognostic and therapeutic study.

Authors:  Alexandre Seidowsky; Saad Nseir; Nicole Houdret; François Fourrier
Journal:  Crit Care Med       Date:  2009-07       Impact factor: 7.598
  10 in total
  3 in total

1.  Further clarifying the relationship between metformin, acute kidney injury and lactic acidosis.

Authors:  Connie M Rhee; Kamyar Kalantar-Zadeh
Journal:  Nat Rev Nephrol       Date:  2017-12-13       Impact factor: 28.314

2.  Risks of Metformin in Type 2 Diabetes and Chronic Kidney Disease: Lessons Learned from Taiwanese Data.

Authors:  Connie M Rhee; Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  Nephron       Date:  2016-10-20       Impact factor: 2.847

3.  Should Restrictions Be Relaxed for Metformin Use in Chronic Kidney Disease? No, We Should Never Again Compromise Safety!

Authors:  Kamyar Kalantar-Zadeh; Csaba P Kovesdy
Journal:  Diabetes Care       Date:  2016-07       Impact factor: 19.112
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.